Mediclinic International plc Director/PDMR Shareholding (6954Q)

TIDMMDC

RNS Number : 6954Q

Mediclinic International plc

22 June 2020

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic", or the "Company", or the "Group")

22 June 2020

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

On 19 June 2020, Mr Gert Hattingh, Group Chief Corporate Services Officer of Mediclinic International plc, sold a total of 25 904 shares in the Company to cover personal tax liabilities. Mr Hattingh continues to hold 100 000 shares in the Company.

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.

 
 1.   Details of PDMR / person closely associated with them 
       ("PCA") 
 a)   Name                      Ghwarriebos Investments (Pty) Ltd 
     ------------------------  ----------------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position / status         PCA of Mr Gert Cornelis Hattingh, Group 
                                 Chief Corporate Services Officer 
     ------------------------  ----------------------------------------- 
 b)   Initial notification      Initial Notification 
       / amendment 
     ------------------------  ----------------------------------------- 
 3.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------- 
 a)   Name                      Mediclinic International plc 
     ------------------------  ----------------------------------------- 
 b)   LEI                       2138002S5BSBIZTD5I60 
     ------------------------  ----------------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------- 
 a)   Description               Ordinary Shares 
       of the financial 
       instrument                GB00B8HX8Z88 
       Identification 
       Code 
     ------------------------  ----------------------------------------- 
 b)   Nature of the             Sale of shares 
       transaction 
     ------------------------  ----------------------------------------- 
 c)   Price(s) and               Price(s) per share    Volume(s) 
       volume(s)                  ZAR 58.37             4 000 
                                                       ---------- 
                                  ZAR 58.43             3 000 
                                                       ---------- 
                                  ZAR 58.46             3 055 
                                                       ---------- 
                                  ZAR 58.47             1 904 
                                                       ---------- 
                                  ZAR 58.48             945 
                                                       ---------- 
                                  ZAR 58.50             4 000 
                                                       ---------- 
                                  ZAR 58.55             2 000 
                                                       ---------- 
                                  ZAR 58.58             3 000 
                                                       ---------- 
                                  ZAR 58.73             3 500 
                                                       ---------- 
                                  ZAR 58.74             500 
                                                       ---------- 
     ------------------------  ----------------------------------------- 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                  25 904 
 
                                  ZAR 58.51 per share 
     ------------------------  ----------------------------------------- 
 e)   Date of the               19 June 2020; 11:12 UTC 
       transaction 
     ------------------------  ----------------------------------------- 
 f)   Place of the              Johannesburg Stock Exchange 
       transaction 
     ------------------------  ----------------------------------------- 
 

About Mediclinic International plc

Mediclinic is an international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates ("UAE").

The Group's core purpose is to enhance the quality of life.

Its vision is to be the partner of choice that people trust for all their healthcare needs.

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

At 1 June 2020, Mediclinic comprised 76 hospitals, eight sub-acute and specialised hospitals, 15 day case clinics and 21 outpatient clinics. Hirslanden operated 17 hospitals, three day case clinics and three outpatient clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operations included 52 hospitals (three of which in Namibia), eight sub-acute and specialised hospitals and 10 day case clinics (four of which operated by Intercare) across South Africa, and more than 8 700 inpatient beds; and Mediclinic Middle East operated seven hospitals, two day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the UAE.

The Company's primary listing is on the London Stock Exchange (" LSE ") in the United Kingdom, with secondary listings on the JSE Ltd in South Africa and the Namibian Stock Exchange in Namibia.

Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.

For further information, please contact:

Company Secretary, Link Company Matters Limited

Caroline Emmet

[phone]

Investor Relations, Mediclinic International plc

James Arnold, Head of Investor Relations

[e-mail]

[phone]

Media queries

FTI Consulting

Ben Atwell/Ciara Martin - UK

[phone]

Sherryn Schooling - South Africa

[phone]

Registered address : 6(th) Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

   Website:   www.mediclinic.com 

Corporate broker (United Kingdom) : Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBSGDLRSDDGGD

(END) Dow Jones Newswires

June 22, 2020 11:00 ET (15:00 GMT)